HK1027374A1 - Hbv mutants and methods for detecting same - Google Patents

Hbv mutants and methods for detecting same

Info

Publication number
HK1027374A1
HK1027374A1 HK00103809A HK00103809A HK1027374A1 HK 1027374 A1 HK1027374 A1 HK 1027374A1 HK 00103809 A HK00103809 A HK 00103809A HK 00103809 A HK00103809 A HK 00103809A HK 1027374 A1 HK1027374 A1 HK 1027374A1
Authority
HK
Hong Kong
Prior art keywords
viral
present
methods
detecting same
hbv mutants
Prior art date
Application number
HK00103809A
Other languages
English (en)
Inventor
Stephen Alister Locarnini
Angeline Ingrid Bartholomeusz
Thein Aye
De Robert A Man
Original Assignee
Melbourne Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melbourne Health filed Critical Melbourne Health
Publication of HK1027374A1 publication Critical patent/HK1027374A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK00103809A 1996-11-08 2000-06-22 Hbv mutants and methods for detecting same HK1027374A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO3519A AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same
PCT/AU1997/000520 WO1998021317A1 (en) 1996-11-08 1997-08-15 Viral variants and methods for detecting same

Publications (1)

Publication Number Publication Date
HK1027374A1 true HK1027374A1 (en) 2001-01-12

Family

ID=3797830

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103809A HK1027374A1 (en) 1996-11-08 2000-06-22 Hbv mutants and methods for detecting same

Country Status (10)

Country Link
US (4) US6555311B1 (xx)
EP (1) EP0964916B1 (xx)
JP (4) JP2001503277A (xx)
AT (1) ATE348880T1 (xx)
AU (1) AUPO351996A0 (xx)
CA (1) CA2270178C (xx)
DE (1) DE69737126T2 (xx)
ES (1) ES2279542T3 (xx)
HK (1) HK1027374A1 (xx)
WO (1) WO1998021317A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AR028149A1 (es) * 1999-07-08 2003-04-30 Innogenetics Nv Deteccion de la resistencia a los farmacos contra la hepatitis b
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US6697858B1 (en) * 2000-08-14 2004-02-24 Telephony@Work Call center
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
WO2003066841A1 (en) * 2002-02-07 2003-08-14 Melbourne Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
US8278432B2 (en) 2002-03-29 2012-10-02 Innogenetics N.V. HBV drug resistance methods
AU2003213874B2 (en) * 2002-04-12 2008-12-04 Austin Health Hepatitis B viral variants with redused susceptibility to nucleoside analogs and uses thereof
EP1499712A4 (en) 2002-04-12 2008-04-16 Melbourne Health HEPATITIS B VIRUS VARIANTS WITH REDUCED SENSITIVITY TO NUCLEOSIDANALOGES AND USE THEREOF
JP4716727B2 (ja) 2002-06-14 2011-07-06 ジェン−プローブ・インコーポレーテッド Ｂ型肝炎ウイルスを検出するための組成物および方法
WO2004031729A2 (en) * 2002-10-01 2004-04-15 Georgetown University Diagnostic for long term response of hbv carrier to 3tc therapy
WO2006097285A1 (en) 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
ES2470318T3 (es) 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
JP2008534020A (ja) 2005-04-08 2008-08-28 メルボルン ヘルス 抗ウイルス性のヌクレオシド剤に耐性を示すｂ型肝炎ウイルスのバリアントおよびその応用法
US8211443B2 (en) 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
KR100790226B1 (ko) 2005-11-03 2008-01-02 연세대학교 산학협력단 독성 간염 유발 감수성을 검출하는 방법
US9175338B2 (en) 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
AU2009325069B2 (en) * 2008-12-11 2015-03-19 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US20230148447A9 (en) 2008-12-11 2023-05-11 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
EP2694686B2 (en) 2011-04-06 2023-07-19 The University of Chicago COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC)
US9238836B2 (en) 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
US9175348B2 (en) 2012-04-24 2015-11-03 Pacific Biosciences Of California, Inc. Identification of 5-methyl-C in nucleic acid templates
AU2020397499A1 (en) * 2019-12-07 2022-06-16 Erasmus University Medical Center Rotterdam Treatment of diseases related to hepatitis B virus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
ZA973367B (en) * 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) * 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
US7405039B2 (en) * 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
US8278432B2 (en) * 2002-03-29 2012-10-02 Innogenetics N.V. HBV drug resistance methods
EP1499712A4 (en) * 2002-04-12 2008-04-16 Melbourne Health HEPATITIS B VIRUS VARIANTS WITH REDUCED SENSITIVITY TO NUCLEOSIDANALOGES AND USE THEREOF
KR101326612B1 (ko) * 2003-10-21 2013-11-12 멜버른 헬스 Ｈｂｖ 변이체 검출 및 응용
ES2470318T3 (es) * 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
WO2006097285A1 (en) * 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
US8211443B2 (en) * 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
JP2008534020A (ja) * 2005-04-08 2008-08-28 メルボルン ヘルス 抗ウイルス性のヌクレオシド剤に耐性を示すｂ型肝炎ウイルスのバリアントおよびその応用法
WO2007140522A1 (en) * 2006-06-06 2007-12-13 Melbourne Health Detection and use of antiviral resistance mutations

Also Published As

Publication number Publication date
DE69737126D1 (de) 2007-02-01
EP0964916A1 (en) 1999-12-22
US20030124096A1 (en) 2003-07-03
DE69737126T2 (de) 2007-10-04
AUPO351996A0 (en) 1996-12-05
US20100203506A1 (en) 2010-08-12
WO1998021317A1 (en) 1998-05-22
JP2008154590A (ja) 2008-07-10
US20130171620A1 (en) 2013-07-04
EP0964916A4 (en) 2001-09-26
ATE348880T1 (de) 2007-01-15
JP2001503277A (ja) 2001-03-13
CA2270178A1 (en) 1998-05-22
CA2270178C (en) 2012-06-12
EP0964916B1 (en) 2006-12-20
JP2015107127A (ja) 2015-06-11
ES2279542T3 (es) 2007-08-16
JP2012055322A (ja) 2012-03-22
US6555311B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
HK1027374A1 (en) Hbv mutants and methods for detecting same
HK1033773A1 (en) An assay for detecting anti-hepatitis c virus and the kit therefor.
HUT73098A (en) Hepatitis c virus (hcv) polypeptides
EP0745128A4 (en) MUTANTS OF HEPATITIS B VIRUS, REAGENTS AND DETECTION METHODS
HUP0001395A3 (en) Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication
AU2001257001A1 (en) Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
PL311653A1 (en) Novel methods of classifying c-type hepatitis viruses and reagents for use in such methods
ZA888170B (en) Enzyme immunoassay for detecting hiv antigens in human sera
CA2032907A1 (en) Hepatitis c assay
EP2360257A3 (en) Hepatitis B virus (HBV) variants
EP1476543A4 (en) VIRUS VARIANTS WITH CHANGED SENSITIVITY TO NUCLEOSIDANALOGES AND USES THEREOF
EP1037974A4 (en) TRUNCATED PROTEIN OF HEPATITIS C VIRUS NS5B AND RELATED METHODS OF IDENTIFYING ANTIVIRAL COMPOUNDS
GB9608626D0 (en) Hepatitis b monoclonal antibodies
AUPQ810900A0 (en) Viral variants and methods of using same
AU1334588A (en) Assay for detecting hepatitis antigens and aids antibodies
NZ215143A (en) Immunoassay and test kit for aids
AU2274599A (en) Adenosine detection in small samples
EP0600000A4 (en) HEPATITIS C DETECTION TEST USING RECOMBINANT ANTIGENS OF THE NS5 REGION.
ZA878303B (en) A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents
AU3211893A (en) Method for determining rheumatoid factors and agents for carrying out the method
PT974055E (pt) Metodo de titulacao de uma composicao viral complexa
IL97597A0 (en) Compositions and methods for enzyme detection assays
IL78445A0 (en) Antibodies to(2'-5')oligo-a-synthetase,an interferon induced enzyme,and an assay for said enzyme and its different subtypes,applying said antibodies
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20170814